PTGX | Protagonist Therapeutics (NASDAQ:PTGX) Rating Lowered to Hold at BidaskClub

Protagonist Therapeutics (NASDAQ:PTGX) was downgraded by BidaskClub from a “buy” rating to a “hold” rating in a research note issued on Tuesday, BidAskClub reports.Several other research firms have also recently weighed in on PTGX.Zacks Investment Research cut shares of Protagonist Therapeutics from a “buy” rating to a “hold” rating in a research report […]Daily Political

PTGX | Nucleic Acid Based Gene Therapy Market Research and Clinical Analysis 2020 – Wave Life Sciences, Imugene, Caperna, Phylogica

Harrisburg, NC — ( SBWIRE ) — 10/19/2020 — Nucleic Acid Based Gene Therapy Global Market Report 2020 provides insightful data about business strategies, qualitative and quantitative analysis of Global Market.The report also calls for market – driven results deriving feasibility studies for client needs.MarketInsightsReports ensures qualified and verifiable aspects of market data operating in […]